189 related articles for article (PubMed ID: 21837402)
1. ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.
Lin P; Sun X; Feng T; Zou H; Jiang Y; Liu Z; Zhao D; Yu X
Mol Cell Biochem; 2012 Jan; 359(1-2):235-43. PubMed ID: 21837402
[TBL] [Abstract][Full Text] [Related]
2. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.
Lin F; Lin P; Zhao D; Chen Y; Xiao L; Qin W; Li D; Chen H; Zhao B; Zou H; Zheng X; Yu X
Cell Prolif; 2012 Jun; 45(3):207-16. PubMed ID: 22469032
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
[TBL] [Abstract][Full Text] [Related]
4. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
5. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
He YY; Council SE; Feng L; Chignell CF
Cancer Res; 2008 May; 68(10):3752-8. PubMed ID: 18483258
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of siRNA targeting ADAM17 on the proliferation of prostate cancer PC-3 cells].
Lin F; Lin P; Liu X; Li D; Liu ZJ; Zou HF; Jiang Y; Zhao XF; Feng JL; Yu XG
Zhonghua Nan Ke Xue; 2012 Aug; 18(8):687-91. PubMed ID: 22934512
[TBL] [Abstract][Full Text] [Related]
8. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
9. ADAM17 promotes glioma cell malignant phenotype.
Zheng X; Jiang F; Katakowski M; Lu Y; Chopp M
Mol Carcinog; 2012 Feb; 51(2):150-64. PubMed ID: 21480393
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.
Katakowski M; Jiang F; Zheng X; Gutierrez JA; Szalad A; Chopp M
Cancer Sci; 2009 Sep; 100(9):1597-604. PubMed ID: 19515085
[TBL] [Abstract][Full Text] [Related]
11. Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells.
Chen J; Xia D; Luo JD; Wang P
Asian J Androl; 2009 Nov; 11(6):669-77. PubMed ID: 19734935
[TBL] [Abstract][Full Text] [Related]
12. ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
Meng X; Hu B; Hossain MM; Chen G; Sun Y; Zhang X
Int J Oncol; 2016 Aug; 49(2):682-90. PubMed ID: 27221510
[TBL] [Abstract][Full Text] [Related]
13. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
Huang L; Chen J; Quan J; Xiang D
Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
16. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex.
Mairet-Coello G; Tury A; DiCicco-Bloom E
J Neurosci; 2009 Jan; 29(3):775-88. PubMed ID: 19158303
[TBL] [Abstract][Full Text] [Related]
17. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.
Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D
Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896
[TBL] [Abstract][Full Text] [Related]
18. Short-period hypoxia increases mouse embryonic stem cell proliferation through cooperation of arachidonic acid and PI3K/Akt signalling pathways.
Lee SH; Lee MY; Han HJ
Cell Prolif; 2008 Apr; 41(2):230-47. PubMed ID: 18336469
[TBL] [Abstract][Full Text] [Related]
19. High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.
Li R; Uttarwar L; Gao B; Charbonneau M; Shi Y; Chan JS; Dubois CM; Krepinsky JC
J Biol Chem; 2015 Aug; 290(35):21603-14. PubMed ID: 26175156
[TBL] [Abstract][Full Text] [Related]
20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
